US Stock MarketDetailed Quotes

PLRX Pliant Therapeutics

Watchlist
  • 1.590
  • +0.110+7.43%
Close Apr 30 16:00 ET
  • 1.590
  • 0.0000.00%
Post 16:21 ET
97.60MMarket Cap-0.46P/E (TTM)

About Pliant Therapeutics Company

Pliant Therapeutics, Inc. engages in the discovery, development and commercialization of therapies for fibrotic diseases. It offers a product discovery engine. The company is pursuing drug development programs for a range of fibrotic diseases, focusing on tissue-specific integrin modulation and TGF-?1 signaling inhibition. The company was founded by Bradley Backes, Bill De Grado, Hal Chapman, and Dean Sheppard in June 2015 and is headquartered in South San Francisco, CA.

Company Profile

SymbolPLRX
Company NamePliant Therapeutics
Listing DateJun 3, 2020
Issue Price16.00
Founded2015
CEODr. Bernard Coulie, M.B.A.,M.D.,PhD
MarketNASDAQ
Employees171
Fiscal Year Ends12-31
Address331 Oyster Point Boulevard
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-481-6770

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Bernard Coulie, M.B.A.,M.D.,PhD
  • Director, President and Chief Executive Officer
  • 6.61M
  • Lily Cheung
  • Chief Human Resources Officer
  • --
  • Mike Ouimette, J.D.
  • Chief Legal and Compliance Officer and Secretary
  • 1.99M
  • Hans Hull, J.D.
  • Chief Business Officer
  • 2.02M
  • Dr. Keith Cummings, M.B.A.,M.D.
  • Chief Financial Officer
  • 3.10M
  • Dr. Eric Lefebvre, M.D.
  • Chief Medical Officer
  • 2.62M
  • Dr. Hoyoung Huh,M.D.,PhD
  • Non-Executive Chairman of the Board and Lead Independent Director
  • 304.65K
  • Smital Shah, M.B.A.
  • Independent Director
  • 281.43K
  • Gayle A. Crowell
  • Independent Director
  • 287.60K
  • Thomas A. McCourt
  • Independent Director
  • 277.85K
  • Steven E. Krognes, M.B.A.
  • Independent Director
  • 501.14K
  • David E.I. Pyott, M.A.,M.B.A.
  • Independent Director
  • 283.05K
  • Darren S. Cline, M.B.A.
  • Independent Director
  • 279.53K
  • Dr. Suzanne L. Bruhn, PhD
  • Independent Director
  • 282.80K
  • Dr. Katharine Knobil, M.D.
  • Independent Director
  • 284.10K
  • Dr. John T. Curnutte, M.D.,PhD
  • Independent Director
  • 276.80K

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Unlock Now

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.